Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized double-blind placebo-controlled study of calf intestinal alkaline phosphatase in sepsis
NL-OMON19934Active, not recruiting
- Sponsor
- AM-Pharma B.V. Rumpsterweg 6 3981 AK Bunnik THE NETHERLANDS Telephone: +31 (0)30 228 9 222 Telefax: +31 (0)30 228 9 220
- Start
- Aug 2004
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in sepsis comparing CIAP with Placebo (2 arms). Primary endpoints: Adverse events, Antibodies against CIAP and 10 more. Started Aug 2004; status: active, not recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
sepsis
Beyond the preview
Go deeper on NL-OMON19934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19934.